Share:
Peer-Reviewed Publication
Med Devices (Auckl)2024;17465-469.January 1, 2024Journal Article

Initial Validation of the NOL Nociception Level Index® Monitoring System in Black and Multiracial People.

Rachel Weissbrod1, Charlene Blake2
1Medasense Biometrics Ltd, Ramat Gan, Israel.
2Department of Anesthesia at the University of San Francisco, San Francisco, CA, USA.

Abstract

The NOL-Nociception Level Index® is a multiparameter index, based on artificial intelligence for the monitoring of nociception (physiological pain response) during anesthesia that has recently been authorized by the FDA. The monitor utilizes continuous streams of information from a finger probe comprising four sensors, including photoplethysmography, to provide a personalized nociception score on…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.